The Unheralded Legacy of Marty Makary's FDA Tenure Marty Makary's resignation as FDA commissioner in May 2026 was met with a mix of relief and disappointment.
While his departure was precipitated by disagreements over e cigarette regulation, it would be a mistake to dismiss the significant reforms he implemented during his tenure as mere controversy.
Beneath the headlines lies a remarkable story of regulatory modernization and innovation.